Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06APK
|
||||
Former ID |
DIB009024
|
||||
Drug Name |
Rinfabate
|
||||
Synonyms |
RhIGFBP-3; Rinfabate, Insmed; RhIGF-BP3, Insmed; Insulin-like growth factor binding protein-3, Insmed
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Phase 2/3 | [521879] | ||
Company |
Insmed Inc
|
||||
CAS Number |
CAS 405341-12-0
|
||||
Target and Pathway | |||||
Target(s) | Insulin-like growth factor I receptor | Target Info | Modulator | [527486] | |
KEGG Pathway | Ras signaling pathway | ||||
Rap1 signaling pathway | |||||
HIF-1 signaling pathway | |||||
FoxO signaling pathway | |||||
Oocyte meiosis | |||||
Endocytosis | |||||
PI3K-Akt signaling pathway | |||||
AMPK signaling pathway | |||||
Focal adhesion | |||||
Adherens junction | |||||
Signaling pathways regulating pluripotency of stem cells | |||||
Long-term depression | |||||
Ovarian steroidogenesis | |||||
Progesterone-mediated oocyte maturation | |||||
Pathways in cancer | |||||
Transcriptional misregulation in cancer | |||||
Proteoglycans in cancer | |||||
Glioma | |||||
Prostate cancer | |||||
Melanoma | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.